A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Masatoshi Kudo
Abstract
achievement of marked tumor shrinkage," which differs from the treatment concept for other types of advanced cancer or advanced HCC. Upfront Systemic Therapy with Subsequent Locoregional Therapy/Resection in Intermediate-Stage HCC
Topics & Concepts
Systemic therapyMedicineStage (stratigraphy)Internal medicineCancerBreast cancerPaleontologyBiologyHepatocellular Carcinoma Treatment and PrognosisLung Cancer Treatments and MutationsCancer, Hypoxia, and Metabolism